Canada markets closed

Medinotec Inc. (MDNC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
5.00000.0000 (0.00%)
At close: 10:33AM EDT

Medinotec Inc.

Northlands Deco Park
10 New Market Street Stand 299 Avant Garde Avenue North Riding
Johannesburg 2169
South Africa
27 87 330 2301
https://www.medinotecinc.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Dr. Gregory VizirgianakisPresident, Secretary, CEO & DirectorN/AN/A1980
Mr. Pieter van NiekerkCFO, Treasurer & DirectorN/AN/A1985
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medinotec Inc. engages in the research and development, production, and sale of medical devices. The company offers semi-compliant percutaneous transluminal coronary angioplasty balloon catheters, suction dissectors, aortic perfusion and dilation catheters, chronic total occlusion catheters, and silicone tracheal stents. It serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations. The company sells its products through the network of distributors and direct sales force. It serves customers in South Africa and internationally. The company was incorporated in 2021 and is based in Johannesburg, South Africa.

Corporate Governance

Medinotec Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.